Pages that link to "Property:RefDocPart"

The following pages link to Property:RefDocPart:

Displaying 50 items.

• Document:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 (← links)
• Document:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 (← links)
• Document:USA FDA Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs — Improving Human Subject Protection Jan-2009 (← links)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Investigations May-2007 (← links)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 (← links)
• Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 (← links)
• Document:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 (← links)
• Document:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 (← links)
• Document:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 (← links)
• Document:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 (← links)
• Document:USA NIH - Glossary 27-May-2025 (← links)
• Document:USA FDA Information - Observations and citations 20-Mar-2024 (← links)
• Document:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 (← links)
• Document:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 (← links)
• Document:USA NIH - SCORE Manual: Appendix Source Documents Requirements Rev 01 16-Aug-2025 (← links)
• Document:USA Recognized Consensus Standards - ISO 14155 21-Dec-2020 (← links)
• Document:USA U.S. Code Title 21 30-Sep-2023 (← links)
• Document:CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 (← links)
• Document:CIOMS CIOMS - International Ethical Guidelines for Health-related Research Involving Humans 2016 (← links)
• Document:ICH ICH E11 Guideline R1 (2017) (← links)
• Document:ICH ICH E19 Guideline 2022 (← links)
• Document:ICH ICH E21 Concept paper 2023 (← links)
• Document:ICH ICH E2A Guideline 1994 (← links)
• Document:ICH ICH E2F Guideline 2010 (← links)
• Document:ICH ICH E3 Guideline 1995 (← links)
• Document:ICH ICH E6 Guideline R3 (2025) (← links)
• Document:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 (← links)
• Document:ICH ICH E7 Guideline 1993 (← links)
• Document:ICH ICH E8 Guideline R1 (2021) (← links)
• Document:ICH ICH E9 Guideline - Addendum R1 20-Nov-2019 (← links)
• Document:ICH ICH E9 Guideline 1998 (← links)
• Document:IMDRF IMDRF – Guidelines - (← links)
• Document:INT ISPE - GPP Revision 3 (2015) (← links)
• Document:INT Nuremberg Code 1947 (← links)
• Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 (← links)
• Document:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 (← links)
• Document:N.A. Article from Mora et al. 2023 (← links)
• Document:N.A. SPIRIT 2013 - Chan et al. 2013 (← links)
• Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report (← links)
• Document:WHO WHO - Guidance for best practices for clinical trials 2024 (← links)
• Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 (← links)
• Document:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 (← links)
• Document:WMA Declaration of Helsinki 2024 (← links)
• Document:DEU Deutsches Ärzteblatt 45849 (← links)
• Document:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 (← links)
• Document:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026 (← links)
• Document:N.A. Minimum Criteria for ICH E6 (R3) GCP Investigator Site Personnel Training V3.0 (← links)
• Document:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025 (← links)
• Document:GBR MHRA GCP Inspection Dossier template V7.0 (← links)
• Document:USA WARNING LETTER - Purolea Cosmetics Lab MARCS-CMS 722591 46114 (← links)